Intensive therapy of type 2 diabetes (ACCORD trial)

Article Type
Changed
Tue, 05/03/2022 - 16:03
Display Headline
Intensive therapy of type 2 diabetes (ACCORD trial)

To the Editor: I certainly enjoyed Dr. Byron J. Hoogwerf’s excellent summary article regarding intensive therapy of type 2 diabetes. I was concerned, however, about the sentence in his last paragraph stating that “any strategy that lowers glucose and is not associated with a risk of hypoglycemia and does not cause excessive weight gain should be considered appropriate in patients with type 2 diabetes.” This statement begs the question: What is excessive weight gain?

In view of the known adverse effects of obesity on hypertension, lipid disorders, and insulin resistance, how can any weight gain be beneficial? Is there any evidence that lowering glucose has any benefit when it is associated with weight gain?

Article PDF
Author and Disclosure Information

John W. Drake, MD
Oklahoma City, OK

Issue
Cleveland Clinic Journal of Medicine - 76(2)
Publications
Topics
Page Number
83-84
Sections
Author and Disclosure Information

John W. Drake, MD
Oklahoma City, OK

Author and Disclosure Information

John W. Drake, MD
Oklahoma City, OK

Article PDF
Article PDF
Related Articles

To the Editor: I certainly enjoyed Dr. Byron J. Hoogwerf’s excellent summary article regarding intensive therapy of type 2 diabetes. I was concerned, however, about the sentence in his last paragraph stating that “any strategy that lowers glucose and is not associated with a risk of hypoglycemia and does not cause excessive weight gain should be considered appropriate in patients with type 2 diabetes.” This statement begs the question: What is excessive weight gain?

In view of the known adverse effects of obesity on hypertension, lipid disorders, and insulin resistance, how can any weight gain be beneficial? Is there any evidence that lowering glucose has any benefit when it is associated with weight gain?

To the Editor: I certainly enjoyed Dr. Byron J. Hoogwerf’s excellent summary article regarding intensive therapy of type 2 diabetes. I was concerned, however, about the sentence in his last paragraph stating that “any strategy that lowers glucose and is not associated with a risk of hypoglycemia and does not cause excessive weight gain should be considered appropriate in patients with type 2 diabetes.” This statement begs the question: What is excessive weight gain?

In view of the known adverse effects of obesity on hypertension, lipid disorders, and insulin resistance, how can any weight gain be beneficial? Is there any evidence that lowering glucose has any benefit when it is associated with weight gain?

Issue
Cleveland Clinic Journal of Medicine - 76(2)
Issue
Cleveland Clinic Journal of Medicine - 76(2)
Page Number
83-84
Page Number
83-84
Publications
Publications
Topics
Article Type
Display Headline
Intensive therapy of type 2 diabetes (ACCORD trial)
Display Headline
Intensive therapy of type 2 diabetes (ACCORD trial)
Sections
Disallow All Ads
Alternative CME
Article PDF Media